首页> 外文OA文献 >1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections

【2h】

1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections

机译：1302.肺炎患者，血栓感染/败血症或复杂尿路感染血浆和上皮衬里血浆和上皮衬液中的Cefiderocol群体药代动力学及靶培养概率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Takayuki Katsube; Nao Kawaguchi; Roger Echols; Toshihiro Wajima; David P Nicolau;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis [J] . Kawaguchi Nao, Katsube Takayuki, Echols Roger, Antimicrobial agents and chemotherapy. . 2018,第2期

机译：Cefiderocol，一种肠胃组合的人口药代动力学分析，在健康受试者中，具有各种肾功能的受试者，以及复杂的泌尿道感染或急性简单的肾盂肾炎患者
2. Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated lntra-abdominal Infections [J] . Larson Kajal B., Patel Yogesh T., Willavize Susan, Antimicrobial agents and chemotherapy. . 2019,第6期

机译：Ceftolozane-Tazobactam人口药代动力学和剂量选择，用于分泌尿路或复杂的LNTra-腹部感染的儿科患者进一步的临床评价
3. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP) [J] . Noreddin AM, Marras TK, Sanders K, International journal of antimicrobial agents . 2004,第5期

机译：使用左氧氟沙星500 mg，750 mg和1000 mg每天一次在住院的社区获得性肺炎（CAP）患者的血浆（P）和上皮衬液（ELF）中对肺炎链球菌的药效学目标实现分析
4. 1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia Bloodstream Infection/Sepsis or Complicated Urinary Tract Infections [O] . Takayuki Katsube, Nao Kawaguchi, Roger Echols, 2020

机译：1302.肺炎患者血栓感染/败血症或复杂尿路感染血浆和上皮衬里血浆和上皮衬液中的Cefiderocol群体药代动力学及靶培养概率
5. Population Pharmacokinetic Analysis of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Healthy Subjects, Subjects with Various Degrees of Renal Function, and Patients with Complicated Urinary Tract Infection or Acute Uncomplicated Pyelonephritis [O] . Nao Kawaguchi, Takayuki Katsube, Roger Echols, 2018

机译：Cefiderocol的人口药代动力学分析，一种肠胃外，肠胃外膀胱孢子素，在健康受试者中，具有各种肾功能的受试者，以及复杂的泌尿道感染或急性简单的肾盂肾炎患者

1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections

著录项

相似文献

相关主题

期刊订阅